🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

DK Medical Technology (Suzhou) clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with DK Medical Technology (Suzhou) as lead sponsor. Synced 26 Sep 2026
3Current trials
2Recruiting now
0Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

DK Medical Technology (Suzhou) is the lead sponsor of 3 current clinical trials in our China register. 2 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is In-Stent Restenosis or De Novo Coronary Artery Lesions.

ClinicalTrials.gov trials by status

  • Recruiting267%
  • Not yet open133%

Trials by phase

  • Not applicable267%
  • Observational133%
01

Clinical trials sponsored by DK Medical Technology (Suzhou)

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis
NCT06422845 · ClinicalTrials.gov ↗ · Arteriovenous Fistula Stenosis
Not applicable Recruiting 2024-09 China
Scoring Balloon and High Pressure Balloon in the Treatment of Arteriovenous Graft Stenosis
NCT06503692 · ClinicalTrials.gov ↗ · Arteriovenous Graft Stenosis
Not applicable Recruiting 2024-08 China
Coronary Artery Drug-Coated Balloon Dilatation Catheter Clinical Trial Protocol
NCT07415902 · ClinicalTrials.gov ↗ · In-Stent Restenosis or De Novo Coronary Artery Lesions
Observational Not yet open 2026-02 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in DK Medical Technology (Suzhou) trials

3 conditions
In-Stent Restenosis or De Novo Coronary Artery Lesions1Arteriovenous Fistula Stenosis1Arteriovenous Graft Stenosis1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in China32

A trial with sites in more than one country appears in each of those registers.

04

Questions about DK Medical Technology (Suzhou) trials

How many clinical trials does DK Medical Technology (Suzhou) sponsor?

DK Medical Technology (Suzhou) is the lead sponsor of 3 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are DK Medical Technology (Suzhou) trials recruiting?

Yes. 2 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.